Emergent BioSolutions Inc (EBS)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG, MD 20879

Emergent BioSolutions Inc. develops, manufactures, and commercializes immunobiotics such as vaccines and immune globulins that assist the body's immune system. The company's biodefense segment develops, manufactures, and commercializes drugs such as BioThrax, a vaccine for the prevention of anthrax, for use against biological agents. Other products in preclinical development include drugs for the treatment of patients after they are exposed to anthrax and botulinum toxin. Emergent's commercial segment develops products for use against infectious diseases. These include a single-dose typhoid vaccine in phase II clinical development; a hepatitis B vaccine in phase II clinical development, and a group B streptococcus vaccine for women of childbearing age for protection of the fetus and newborn babies, which is in phase I clinical trials. Emergent is also developing chlamydia and meningitis B vaccines. Emergent primarily works for the U.S. Defense and Health & Human Services departments. It has collaboration agreements with the British Health Protection Agency for the development of a human botulinum immune globulin candidate and with Sanofi Pasteur for the development of meningitis B vaccine candidate.

Data as of 2021-04-17 09:53:32 -0400
Market Cap4.16 Billion Shares Outstanding53.577 Million Avg 30-day Volume935.645 Thousand
P/E Ratio13.63393 Dividend Yield0.0 EPS5.67
Price/Sales2.65 Debt to Equity1.99 EBITDA493.6 Million
Price to Book Value2.85 Forward PE8.39 Enterprise Value4.376 Billion
Total Cash621.3 Million Current Debt384.5 Million Gross Profit1.031 Billion
BETA1.00576 52-week High/Low137.61 / 66.01 Next Earnings Date2021-04-29 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from EBS instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 2 5 -60.0% 2 (0.12%) 2 (0.12%) 0.0%
Funds Holding: 342 353 -3.12% 83 (4.99%) 99 (6.16%) -16.16%
13F shares: 44.142 Million 42.628 Million 3.55% 10.015 Million 10.808 Million -7.34%
% Ownership 83.2884 80.4312 3.55% 18.8958 20.3926 -7.34%
New Positions: 53 87 -39.08% 10 24 -58.33%
Increased Positions 152 109 39.45% 40 35 14.29%
Closed Positions 60 27 122.22% 27 8 237.5%
Reduced Positions 107 135 -20.74% 28 37 -24.32%
Total Calls 207.645 Thousand 107.73 Thousand 92.75% 44.8 Thousand 27.3 Thousand 64.1%
Total Puts 205.222 Thousand 68.517 Thousand 199.52% 33.2 Thousand 21.9 Thousand 51.6%
PUT/CALL Ratio 0.99 0.64 54.69% 0.74 0.8 -7.5%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding EBS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding EBS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

45.4 Thousand total shares from 3 transactions

Exercise Derivative Conversion (M)

37.3 Thousand total shares from 2 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

KIRK SEAN EVP, MANUFACTURING & TECH OPS

  • Officer
17,776 2021-03-31 2

BAILEY SUE

  • Director
24,427 2021-03-04 4

HAVEY ADAM EVP, BUSINESS OPERATIONS

  • Officer
38,190 2021-03-01 3

EL-HIBRI FUAD CHAIRMAN

  • Officer
  • Director
41,714 2021-02-24 8

KRAMER ROBERT PRESIDENT AND CEO

  • Officer
  • Director
388,768 2021-02-24 6

STREI KATHERINE EVP, CHIEF HR OFFICER

  • Officer
74,906 2021-02-24 3

SARAN ATUL EVP, CORP DEV, GC & SECRETARY

  • Officer
106,056 2021-02-24 3

LINDAHL RICHARD S EVP, CHIEF FINANCIAL OFFICER

  • Officer
92,808 2021-02-24 3

SMITH KAREN L. EVP, CHIEF MEDICAL OFFICER

  • Officer
23,958 2021-02-24 2

WHITE MARVIN L

  • Director
3,629 2020-10-01 2

SULLIVAN LOUIS W

  • Director
32,758 2020-09-16 3

HARSANYI ZSOLT

  • Director
24,579 2020-08-17 4

JOULWAN GEORGE A

  • Director
26,771 2020-08-11 3

ZOON KATHRYN C

  • Director
12,489 2020-08-10 4

RICHARD RONALD

  • Director
8,276 2020-08-07 5

HAUER JEROME M

  • Director
10,188 2020-05-26 2

EMERGENT BIOSOLUTIONS INC.

  • SEAN KIRK, EVP, MANUFACTURING
13,604 2019-05-23 0

MULLIGAN SEAMUS

  • Director
594,162 2019-03-19 0

ABDUN-NABI DANIEL CEO

  • Officer
  • Director
144,553 2019-03-04 0

NIEDERHUBER JOHN

  • Director
No longer subject to file 2016-05-18 0

LABINGER BARRY EVP, BIOSCIENCES DIV.

  • Officer
25,182 2015-11-13 0

CHATFIELD STEVEN EVP, BIOSCIENCES

  • Officer
28,000 2013-03-14 0

INTERVAC, L.L.C.

  • 10% Owner
4,344,250 2012-09-18 0

ELSEY R DON CHIEF FINANCIAL OFFICER

  • Officer
26,614 2012-03-13 0

KEESE KYLE EVP, BIOSCIENCES DIVISION

  • Officer
18,759 2011-03-15 0

LOCKHART STEPHEN SVP PRODUCT DEVELOPMENT

  • Officer
6,980 2010-11-11 0

BIOPHARM, L.L.C.

  • 10% Owner
No longer subject to file 2010-05-27 0

ESPOSITO DENISE CLO

  • Officer
0 2009-03-10 0

BIOLOGIKA, L.L.C.

  • MEMBER 13(D) GROUP OWNING >10%
1,399,764 2008-06-04 0

ALLBAUGH JOE M

  • Director
0 2008-05-21 0

MICHIGAN BIOLOGIC PRODUCTS, INC.

  • MEMBER 13(D) GROUP OWNING >10%
1,328,018 2008-01-14 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

KIRK SEAN - Officer EVP, MANUFACTURING & TECH OPS

2021-04-01 18:54:16 -0400 2021-03-31 F 159 d 17,776 direct 0.8013 -3.5106 0.8013 2 -3.5106 6

BAILEY SUE - Director

2021-03-08 18:30:56 -0500 2021-03-04 S 8,168 $92.37 d 24,427 direct 3.0348 6.9433 6.9433 6 0.0 1

HAVEY ADAM - Officer EVP, BUSINESS OPERATIONS

2021-03-03 18:07:30 -0500 2021-03-01 S 20,145 $99.02 d 38,190 direct 1.5847 1.1335 -14.5593 4.578 13 -19.9296 28

HAVEY ADAM - Officer EVP, BUSINESS OPERATIONS

2021-03-03 18:07:30 -0500 2021-03-01 M 17,134 $30.63 a 55,324 direct 1.5847 1.1335 -14.5593 4.578 13 -19.9296 28

HAVEY ADAM - Officer EVP, BUSINESS OPERATIONS

2021-03-03 18:07:30 -0500 2021-03-01 M 20,145 $99.02 d 0 direct yes

HAVEY ADAM - Officer EVP, BUSINESS OPERATIONS

2021-03-03 18:07:30 -0500 2021-03-01 M 20,145 $49.64 a 58,335 direct 1.5847 1.1335 -14.5593 4.578 13 -19.9296 28

HAVEY ADAM - Officer EVP, BUSINESS OPERATIONS

2021-03-03 18:07:30 -0500 2021-03-01 M 17,134 $99.62 d 0 direct yes

HAVEY ADAM - Officer EVP, BUSINESS OPERATIONS

2021-03-03 18:07:30 -0500 2021-03-01 S 17,134 $99.62 d 38,190 direct 1.5847 1.1335 -14.5593 4.578 13 -19.9296 28

HAVEY ADAM - Officer EVP, BUSINESS OPERATIONS

2021-02-26 17:18:16 -0500 2021-02-26 F 739 $97.15 d 38,922 direct -2.8376 -15.6262 -28.8063 0.0 1 -28.8063 31

STREI KATHERINE - Officer EVP, CHIEF HR OFFICER

2021-02-26 17:14:45 -0500 2021-02-26 F 649 $97.15 d 32,061 direct -2.8376 -15.6262 -28.8063 0.0 1 -28.8063 31

KRAMER ROBERT - Director - Officer PRESIDENT AND CEO

2021-02-26 17:17:35 -0500 2021-02-26 F 1,716 $97.15 d 164,007 direct -2.8376 -15.6262 -28.8063 0.0 1 -28.8063 31

SARAN ATUL - Officer EVP, CORP DEV, GC & SECRETARY

2021-02-26 17:15:12 -0500 2021-02-26 F 764 $97.15 d 45,559 direct -2.8376 -15.6262 -28.8063 0.0 1 -28.8063 31

KIRK SEAN - Officer EVP, MANUFACTURING & TECH OPS

2021-02-26 17:16:39 -0500 2021-02-26 F 285 d 17,935 direct -2.8376 -15.6262 -28.8063 0.0 1 -28.8063 31

HAVEY ADAM - Officer EVP, BUSINESS OPERATIONS

2021-02-26 17:18:16 -0500 2021-02-26 F 732 $97.15 d 38,190 direct -2.8376 -15.6262 -28.8063 0.0 1 -28.8063 31

STREI KATHERINE - Officer EVP, CHIEF HR OFFICER

2021-02-26 17:14:45 -0500 2021-02-26 F 561 $97.15 d 31,500 direct -2.8376 -15.6262 -28.8063 0.0 1 -28.8063 31

KRAMER ROBERT - Director - Officer PRESIDENT AND CEO

2021-02-26 17:17:35 -0500 2021-02-26 F 860 $97.15 d 163,147 direct -2.8376 -15.6262 -28.8063 0.0 1 -28.8063 31

SARAN ATUL - Officer EVP, CORP DEV, GC & SECRETARY

2021-02-26 17:15:12 -0500 2021-02-26 F 799 $97.15 d 44,760 direct -2.8376 -15.6262 -28.8063 0.0 1 -28.8063 31

KIRK SEAN - Officer EVP, MANUFACTURING & TECH OPS

2021-02-26 17:16:39 -0500 2021-02-26 F 336 d 18,220 direct -2.8376 -15.6262 -28.8063 0.0 1 -28.8063 31

LINDAHL RICHARD S - Officer EVP, CHIEF FINANCIAL OFFICER

2021-02-26 17:12:59 -0500 2021-02-26 F 819 $97.15 d 37,973 direct -2.8376 -15.6262 -28.8063 0.0 1 -28.8063 31

KIRK SEAN - Officer EVP, MANUFACTURING & TECH OPS

2021-02-26 17:16:39 -0500 2021-02-24 A 3,209 a 15,780 direct -2.8376 -15.6262 -28.8063 0.0 1 -28.8063 31

LINDAHL RICHARD S - Officer EVP, CHIEF FINANCIAL OFFICER

2021-02-26 17:12:59 -0500 2021-02-24 A 4,011 a 35,790 direct -2.8376 -15.6262 -28.8063 0.0 1 -28.8063 31

HAVEY ADAM - Officer EVP, BUSINESS OPERATIONS

2021-02-26 17:18:16 -0500 2021-02-24 A 3,744 a 36,764 direct -2.8376 -15.6262 -28.8063 0.0 1 -28.8063 31

STREI KATHERINE - Officer EVP, CHIEF HR OFFICER

2021-02-26 17:14:45 -0500 2021-02-24 A 2,674 a 30,655 direct -2.8376 -15.6262 -28.8063 0.0 1 -28.8063 31

KRAMER ROBERT - Director - Officer PRESIDENT AND CEO

2021-02-26 17:17:35 -0500 2021-02-24 A 14,975 a 153,173 direct -2.8376 -15.6262 -28.8063 0.0 1 -28.8063 31

SARAN ATUL - Officer EVP, CORP DEV, GC & SECRETARY

2021-02-26 17:15:12 -0500 2021-02-24 A 3,744 a 43,466 direct -2.8376 -15.6262 -28.8063 0.0 1 -28.8063 31

KIRK SEAN - Officer EVP, MANUFACTURING & TECH OPS

2021-02-26 17:16:39 -0500 2021-02-24 A 12,835 $93.49 a 12,835 direct

SMITH KAREN L. - Officer EVP, CHIEF MEDICAL OFFICER

2021-02-26 17:15:59 -0500 2021-02-24 A 2,942 a 9,252 direct -2.8376 -15.6262 -28.8063 0.0 1 -28.8063 31

KIRK SEAN - Officer EVP, MANUFACTURING & TECH OPS

2021-02-26 17:16:39 -0500 2021-02-24 F 433 d 18,556 direct -2.8376 -15.6262 -28.8063 0.0 1 -28.8063 31

LINDAHL RICHARD S - Officer EVP, CHIEF FINANCIAL OFFICER

2021-02-26 17:12:59 -0500 2021-02-24 F 1,010 $93.49 d 38,792 direct -2.8376 -15.6262 -28.8063 0.0 1 -28.8063 31

HAVEY ADAM - Officer EVP, BUSINESS OPERATIONS

2021-02-26 17:18:16 -0500 2021-02-24 A 14,973 $93.49 a 14,973 direct

HAVEY ADAM - Officer EVP, BUSINESS OPERATIONS

2021-02-26 17:18:16 -0500 2021-02-24 F 847 $93.49 d 39,661 direct -2.8376 -15.6262 -28.8063 0.0 1 -28.8063 31

STREI KATHERINE - Officer EVP, CHIEF HR OFFICER

2021-02-26 17:14:45 -0500 2021-02-24 A 10,696 $93.49 a 10,696 direct

STREI KATHERINE - Officer EVP, CHIEF HR OFFICER

2021-02-26 17:14:45 -0500 2021-02-24 F 619 $93.49 d 32,710 direct -2.8376 -15.6262 -28.8063 0.0 1 -28.8063 31

KRAMER ROBERT - Director - Officer PRESIDENT AND CEO

2021-02-26 17:17:35 -0500 2021-02-24 A 59,898 $93.49 a 59,898 direct

KRAMER ROBERT - Director - Officer PRESIDENT AND CEO

2021-02-26 17:17:35 -0500 2021-02-24 F 2,425 $93.49 d 165,723 direct -2.8376 -15.6262 -28.8063 0.0 1 -28.8063 31

SARAN ATUL - Officer EVP, CORP DEV, GC & SECRETARY

2021-02-26 17:15:12 -0500 2021-02-24 A 14,973 $93.49 a 14,973 direct

SARAN ATUL - Officer EVP, CORP DEV, GC & SECRETARY

2021-02-26 17:15:12 -0500 2021-02-24 F 887 $93.49 d 46,323 direct -2.8376 -15.6262 -28.8063 0.0 1 -28.8063 31

EL-HIBRI FUAD - Director - Officer CHAIRMAN

2021-02-26 19:22:37 -0500 2021-02-24 A 13,906 a 13,906 direct

SMITH KAREN L. - Officer EVP, CHIEF MEDICAL OFFICER

2021-02-26 17:15:59 -0500 2021-02-24 A 11,765 $93.49 a 11,765 direct

LINDAHL RICHARD S - Officer EVP, CHIEF FINANCIAL OFFICER

2021-02-26 17:12:59 -0500 2021-02-24 A 16,043 $93.49 a 16,043 direct

KIRK SEAN - Officer EVP, MANUFACTURING & TECH OPS

2021-02-26 17:16:39 -0500 2021-02-24 A 3,209 a 18,989 direct -2.8376 -15.6262 -28.8063 0.0 1 -28.8063 31

LINDAHL RICHARD S - Officer EVP, CHIEF FINANCIAL OFFICER

2021-02-26 17:12:59 -0500 2021-02-24 A 4,012 a 39,802 direct -2.8376 -15.6262 -28.8063 0.0 1 -28.8063 31

HAVEY ADAM - Officer EVP, BUSINESS OPERATIONS

2021-02-26 17:18:16 -0500 2021-02-24 A 3,744 a 40,508 direct -2.8376 -15.6262 -28.8063 0.0 1 -28.8063 31

STREI KATHERINE - Officer EVP, CHIEF HR OFFICER

2021-02-26 17:14:45 -0500 2021-02-24 A 2,674 a 33,329 direct -2.8376 -15.6262 -28.8063 0.0 1 -28.8063 31

KRAMER ROBERT - Director - Officer PRESIDENT AND CEO

2021-02-26 17:17:35 -0500 2021-02-24 A 14,975 a 168,148 direct -2.8376 -15.6262 -28.8063 0.0 1 -28.8063 31

SARAN ATUL - Officer EVP, CORP DEV, GC & SECRETARY

2021-02-26 17:15:12 -0500 2021-02-24 A 3,744 a 47,210 direct -2.8376 -15.6262 -28.8063 0.0 1 -28.8063 31

EL-HIBRI FUAD - Director - Officer CHAIRMAN

2021-02-26 19:22:37 -0500 2021-02-24 A 27,808 a 27,808 direct

SMITH KAREN L. - Officer EVP, CHIEF MEDICAL OFFICER

2021-02-26 17:15:59 -0500 2021-02-24 A 2,941 a 12,193 direct -2.8376 -15.6262 -28.8063 0.0 1 -28.8063 31

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
EMERGENT BIOSOLUTIONS INC EBS 2021-04-20 22:15:03 UTC -0.19 0.25 2100000
EMERGENT BIOSOLUTIONS INC EBS 2021-04-20 21:45:03 UTC -0.19 0.25 2100000
EMERGENT BIOSOLUTIONS INC EBS 2021-04-20 21:15:02 UTC -0.19 0.25 2100000
EMERGENT BIOSOLUTIONS INC EBS 2021-04-20 20:45:03 UTC -0.19 0.25 2100000
EMERGENT BIOSOLUTIONS INC EBS 2021-04-20 20:15:04 UTC -0.19 0.25 2100000
EMERGENT BIOSOLUTIONS INC EBS 2021-04-20 19:45:03 UTC -0.19 0.25 2100000
EMERGENT BIOSOLUTIONS INC EBS 2021-04-20 19:15:03 UTC -0.19 0.25 2100000
EMERGENT BIOSOLUTIONS INC EBS 2021-04-20 18:45:03 UTC -0.19 0.25 2100000
EMERGENT BIOSOLUTIONS INC EBS 2021-04-20 18:15:03 UTC -0.19 0.25 2100000
EMERGENT BIOSOLUTIONS INC EBS 2021-04-20 17:45:02 UTC -0.19 0.25 2100000
EMERGENT BIOSOLUTIONS INC EBS 2021-04-20 17:15:02 UTC -0.19 0.25 2100000
EMERGENT BIOSOLUTIONS INC EBS 2021-04-20 16:45:03 UTC -0.19 0.25 2100000
EMERGENT BIOSOLUTIONS INC EBS 2021-04-20 16:15:03 UTC -0.19 0.25 2100000
EMERGENT BIOSOLUTIONS INC EBS 2021-04-20 15:45:03 UTC -0.19 0.25 2100000
EMERGENT BIOSOLUTIONS INC EBS 2021-04-20 15:15:02 UTC -0.19 0.25 2100000
EMERGENT BIOSOLUTIONS INC EBS 2021-04-20 14:45:03 UTC -0.19 0.25 2100000
EMERGENT BIOSOLUTIONS INC EBS 2021-04-20 14:15:03 UTC -0.19 0.25 2100000
EMERGENT BIOSOLUTIONS INC EBS 2021-04-20 13:45:03 UTC -0.19 0.25 2000000
EMERGENT BIOSOLUTIONS INC EBS 2021-04-20 13:15:04 UTC -0.19 0.25 2000000
EMERGENT BIOSOLUTIONS INC EBS 2021-04-20 12:45:03 UTC -0.19 0.25 2000000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
RUSSELL INVESTMENT CO- U.S. Small Cap Equity Fund EBS -7852.0 shares, $-706444.44 2020-10-31 N-PORT
FundVantage Trust- Gotham Defensive Long Fund EBS -57.0 shares, $-3298.02 2020-03-31 N-PORT
INVESTMENT MANAGERS SERIES TRUST- AAM HIMCO Global Enhanced Dividend Fund EBS -1406.0 shares, $-125977.6 2020-12-31 N-PORT
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund EBS -2300.0 shares, $-206080.0 2020-12-31 N-PORT
RUSSELL INVESTMENT CO- U.S. Dynamic Equity Fund EBS -953.0 shares, $-101828.05 2021-01-31 N-PORT

Elevate your investments